
Michael D. Pak
Examiner (ID: 3628, Phone: (571)272-0879 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1674, 1621, 1646, 1812, 0 |
| Total Applications | 1549 |
| Issued Applications | 718 |
| Pending Applications | 268 |
| Abandoned Applications | 570 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6425910
[patent_doc_number] => 20100151497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'FLUORESCENCE-BASED ASSAY FOR DETECTING COMPOUNDS FOR MODULATING THE SODIUM-CALCIUM EXCHANGER (NCX) IN \"FORWARD MODE\"'
[patent_app_type] => utility
[patent_app_number] => 12/529230
[patent_app_country] => US
[patent_app_date] => 2008-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5640
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529230 | FLUORESCENCE-BASED ASSAY FOR DETECTING COMPOUNDS FOR MODULATING THE SODIUM-CALCIUM EXCHANGER (NCX) IN "FORWARD MODE" | Mar 3, 2008 | Abandoned |
Array
(
[id] => 4719424
[patent_doc_number] => 20080241947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Intestinal folate transporter'
[patent_app_type] => utility
[patent_app_number] => 12/074371
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19705
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241947.pdf
[firstpage_image] =>[orig_patent_app_number] => 12074371
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/074371 | Intestinal folate transporter method | Mar 2, 2008 | Issued |
Array
(
[id] => 4821824
[patent_doc_number] => 20080227140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'TRP/HIS Exchange and Kynurenine Induced TRP Transport'
[patent_app_type] => utility
[patent_app_number] => 12/040524
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26514
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227140.pdf
[firstpage_image] =>[orig_patent_app_number] => 12040524
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/040524 | Trp/his exchange and kynurenine induced Trp transport | Feb 28, 2008 | Issued |
Array
(
[id] => 4960552
[patent_doc_number] => 20080274977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Treating stroke and other diseases without inhibiting N-type calcium channels'
[patent_app_type] => utility
[patent_app_number] => 12/040851
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15435
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12040851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/040851 | Treating stroke and other diseases without inhibiting N-type calcium channels | Feb 28, 2008 | Issued |
Array
(
[id] => 6383041
[patent_doc_number] => 20100317028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'BIOASSAY METHOD FOR YOKUKANSAN'
[patent_app_type] => utility
[patent_app_number] => 12/867514
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2947
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317028.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867514
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867514 | Bioassay method for yokukansan with serotonin receptor | Feb 14, 2008 | Issued |
Array
(
[id] => 6231405
[patent_doc_number] => 20100184662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'METHOD FOR ASSAYING ANTIBODIES IN BODY FLUIDS BY IMMUNE REACTION WITH GLYCOPROTEIN 2 (GP2) FROM ZYMOGENIC GRANULES OF THE PANCREAS FOR THE DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY INTESTINAL DISEASES AND CHRONIC PANCREATITIS'
[patent_app_type] => utility
[patent_app_number] => 12/523997
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11323
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184662.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523997
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523997 | Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis | Jan 27, 2008 | Issued |
Array
(
[id] => 6588643
[patent_doc_number] => 20100061986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Chronic Rejection Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/524041
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12251
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061986.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524041 | Chronic rejection inhibitor | Jan 22, 2008 | Issued |
Array
(
[id] => 6588643
[patent_doc_number] => 20100061986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Chronic Rejection Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/524041
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12251
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061986.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524041 | Chronic rejection inhibitor | Jan 22, 2008 | Issued |
Array
(
[id] => 6588643
[patent_doc_number] => 20100061986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Chronic Rejection Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/524041
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12251
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061986.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524041 | Chronic rejection inhibitor | Jan 22, 2008 | Issued |
Array
(
[id] => 6588643
[patent_doc_number] => 20100061986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Chronic Rejection Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/524041
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12251
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061986.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524041 | Chronic rejection inhibitor | Jan 22, 2008 | Issued |
Array
(
[id] => 4740817
[patent_doc_number] => 20080234470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'KCNB: A NOVEL POTASSIUM CHANNEL PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 11/968795
[patent_app_country] => US
[patent_app_date] => 2008-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25547
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11968795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/968795 | KCNB: A NOVEL POTASSIUM CHANNEL PROTEIN | Jan 2, 2008 | Abandoned |
Array
(
[id] => 11677072
[patent_doc_number] => 09675578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane'
[patent_app_type] => utility
[patent_app_number] => 12/519126
[patent_app_country] => US
[patent_app_date] => 2007-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 39844
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519126
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519126 | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane | Dec 13, 2007 | Issued |
Array
(
[id] => 4682251
[patent_doc_number] => 20080248477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 12/001395
[patent_app_country] => US
[patent_app_date] => 2007-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 84770
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248477.pdf
[firstpage_image] =>[orig_patent_app_number] => 12001395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/001395 | Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor | Dec 10, 2007 | Abandoned |
Array
(
[id] => 4751885
[patent_doc_number] => 20080159958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'DETERMINATION OF HISTAMINE-3 BIOACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 11/950560
[patent_app_country] => US
[patent_app_date] => 2007-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8571
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20080159958.pdf
[firstpage_image] =>[orig_patent_app_number] => 11950560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/950560 | DETERMINATION OF HISTAMINE-3 BIOACTIVITY | Dec 4, 2007 | Abandoned |
Array
(
[id] => 6588520
[patent_doc_number] => 20100061979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WSITH IMPROVED BIOLOGICAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/515463
[patent_app_country] => US
[patent_app_date] => 2007-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15924
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061979.pdf
[firstpage_image] =>[orig_patent_app_number] => 12515463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/515463 | Modified soluble FGF receptor Fc fusions with improved biological activity | Nov 27, 2007 | Issued |
Array
(
[id] => 4845490
[patent_doc_number] => 20080181898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Wise/sost nucleic acid sequences and amino acid sequences'
[patent_app_type] => utility
[patent_app_number] => 11/985836
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 36683
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985836 | Method of modulating Sost binding to LRP | Nov 15, 2007 | Issued |
Array
(
[id] => 356161
[patent_doc_number] => 07488597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-10
[patent_title] => 'Polynucleotide encoding an intracellular estradiol binding protein'
[patent_app_type] => utility
[patent_app_number] => 11/939001
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11879
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/488/07488597.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939001 | Polynucleotide encoding an intracellular estradiol binding protein | Nov 12, 2007 | Issued |
Array
(
[id] => 6636310
[patent_doc_number] => 20100035814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'N-Terminal Pegylated Prolactin Receptor Molecules'
[patent_app_type] => utility
[patent_app_number] => 12/513578
[patent_app_country] => US
[patent_app_date] => 2007-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15751
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513578
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513578 | N-Terminal Pegylated Prolactin Receptor Molecules | Nov 8, 2007 | Abandoned |
Array
(
[id] => 6431289
[patent_doc_number] => 20100143386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs'
[patent_app_type] => utility
[patent_app_number] => 12/513413
[patent_app_country] => US
[patent_app_date] => 2007-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7355
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143386.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513413
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513413 | FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs | Nov 1, 2007 | Abandoned |
Array
(
[id] => 5551813
[patent_doc_number] => 20090285799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'Antibody Antagonists of Interleukin-13 Receptor Alpha1'
[patent_app_type] => utility
[patent_app_number] => 12/445759
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23133
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285799.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445759
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445759 | Antibody antagonists of interleukin-13 receptor α1 | Oct 18, 2007 | Issued |